Júnior Ferreira
Daily Remedy unveiled two courses for physicians and health administrators to participate in.
The first course explains how to develop and submit amicus briefs for healthcare cases.
The second course details common investigational tactics used by federal authorities to target physicians.
You can register for either course at the link below:
https://www.daily-remedy.com/courses/
#thedailyremedy
Can lowering tau biology translate into a clinically meaningful slowing of decline in people with early symptomatic Alzheimer’s disease? That is the practical question behind BIIB080, an intrathecal antisense therapy designed to reduce production of tau protein by targeting the tau gene transcript. In a phase 1b program originally designed for safety and dosing, investigators later examined cognitive, functional, and global outcomes as exploratory endpoints. The clinical question matters because current disease-modifying options primarily target amyloid, while tau pathology tracks...
Read more
